Search Results - "Wielders, Pascal"

Population Pharmacokinetics and Pharmacodynamics of GSK961081 (Batefenterol), a Muscarinic Antagonist and β2-Agonist, in Moderate-to-Severe COPD Patients: Substudy of a Randomized Trial.

Authors: Ambery, Claire L. Wielders, Pascal Ludwig-Sengpiel, Andrea et al.

Source: Drugs in R&D. Sep2015, Vol. 15 Issue 3, p281-291. 11p.

Identifying a nasal gene expression signature associated with hyperinflation and treatment response in severe COPD.

Authors: Faiz, Alen Imkamp, Kai van der Wiel, Erica et al.

Source: Scientific Reports. 10/15/2020, Vol. 10 Issue 1, pN.PAG-N.PAG. 1p.

Nasal gene expression differentiates COPD from controls and overlaps bronchial gene expression.

Authors: Boudewijn, Ilse M. Faiz, Alen Steiling, Katrina et al.

Source: Respiratory Research. 12/21/2017, Vol. 18, p1-10. 10p. 2 Diagrams, 2 Charts.

Effect of once-daily fluticasone furoate/vilanterol versus vilanterol alone on bone mineral density in patients with COPD: a randomized, controlled trial.

Authors: Maltais, Francois Schenkenberger, Isabelle Wielders, Pascal L. M. L. et al.

Source: Therapeutic advances in respiratory disease Jan-Dec2020.

Journal Info: Publisher: Sage Publications Inc. ISSN: 1753-4658